Skip to content

MDN Pharmaceutics

Active
Private limited companyfounded 2025active for less than a yearIeperlaan 34, 1000 Brussel, BelgiumKBO/BCE: BE 1032.175.218

From the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette

Summary

MDN Pharmaceutics is less than twelve months old. There is no public track record yet to compute a bankruptcy probability from. The annual accounts of MDN Pharmaceutics for financial year 2025 show a net loss of 56% of total assets. The 2025 annual accounts show equity of €873 and a net result of -€1,127. Its solvency ranks better than 58% of 12,757 sector peers (NACE 47, financial year 2025). The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
MDN PharmaceuticsActiveChecked score 43/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 24-12-2025 Normal situation
Legal form
Private limited company
Registered office
Ieperlaan 34, 1000 Brussel
Activity
Retail sale of pharmaceutical products NACE 47730and 4 others
Establishment unit
2.385.355.407 1000 Brussel, since 24-12-2025
Financial year end
31 December
Peppol
Reachable since 13-03-2026
Company details

Board and ownership

Board
Board & ownership

Financial position

43 Weak Checked score 2025
Too young for a bankruptcy probability
Annual accounts 2025
Gross margin
-€1,127
Loss
€1,127
Equity
€873
Total assets
€2,000
Turnover not published (abbreviated format)2025 accounts filed 10 days after the deadline
Filed on 10-08-2026at the National Bank
Financials
Signalsraises riskYoung company2025 accounts filed 10 days lateShow the evidence

Checked score

Score 2025
43 / 100
Weak
Without a bankruptcy probability, the score rests on the figures alone.
Every signal that counts is listed under Signals.
Financial strength
Weak
Solvency 69
equity 43.7% of total assets
Liquidity 61
short-term debt 56.3% · cash 32.3%
Profitability 0
return on assets -56.3%
Bankruptcy probability within 12 months

The company is less than 12 months old. Its public track record is still too short for a reliable bankruptcy probability.

No publishable credit limit, so credit only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
The balance sheet total is too small for a liquidity verdict.
Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Two signals.
raises risk
raises risk · Young company
Founded in 2025, less than a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years under a year 0 10 years
raises risk · 2025 accounts filed 10 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-08-2026, 10 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filing
Deviation from the deadline
2025
10 days late
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2025.
KBO publications

Key points

  • Caution: Less equity than 86% of companies in retail tradesector median €236,771 · 12,767 companies €873 View

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about MDN Pharmaceutics

What is the company number of MDN Pharmaceutics?
The company number of MDN Pharmaceutics is 1032.175.218. The VAT number is the same number with BE in front: BE 1032.175.218.
Where is MDN Pharmaceutics based?
The registered office is at Ieperlaan 34, 1000 Brussel.Company details
What does MDN Pharmaceutics do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of MDN Pharmaceutics?
The legal form of MDN Pharmaceutics is Private limited company (BV).
When was MDN Pharmaceutics founded?
MDN Pharmaceutics was founded on 24-12-2025.
Is MDN Pharmaceutics still active?
Yes, MDN Pharmaceutics is an active enterprise in the KBO register.
What is the turnover of MDN Pharmaceutics?
The annual accounts for financial year 2025 state no turnover. The abbreviated format does not require it.Financials
Is MDN Pharmaceutics profitable?
In financial year 2025, MDN Pharmaceutics made a loss of €1,127.
Where can I find the annual accounts of MDN Pharmaceutics?
MDN Pharmaceutics filed 1 annual account with the National Bank of Belgium, for financial year 2025.Annual accounts at the National Bank

Comparable companies

These companies have the same main activity as MDN Pharmaceutics: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €608 and €7,560, founded between 2021 and 2025.

CompanyTotal assetsGross margin
MDN Pharmaceutics Brussel€2,000-€1,127
Green Pharma Elsene€948-€1,300
BELESSENTIAL Sprimont€2,839-€103
PHARMAWINGS Pittem€7,404-€1,409
DESTOCK PHARMA Eghezée€608-€752
Ibo Drive Brussel€7,557-€7,707
AJPhar Waterloo€6,429-€447
Full comparison

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure